Topical sirolimus therapy for nevus sebaceus and epidermal nevus: A case series - 16/07/22
Doi : 10.1016/j.jaad.2021.08.029
Amanda G. Zhou, BS a, Richard J. Antaya, MD b, ⁎ 
a Yale University School of Medicine, New Haven, Connecticut
b Departments of Dermatology and Pediatrics, Yale University School of Medicine, New Haven, Connecticut
∗Correspondence to: Richard J. Antaya, MD, Department of Dermatology, Yale University School of Medicine, 333 Cedar St, PO Box 208059, New Haven, CT 06520-8059Department of DermatologyYale University School of Medicine333 Cedar St, PO Box 208059New HavenCT06520-8059
| Funding sources: None. |
|
| IRB approval status: This case series was exempt from IRB review as determined by the Yale IRB (Protocol ID 2000028582.) |
|
| Key words: cream; epidermal nevus; nevus sebaceus; organoid nevus; rapamycin; sirolimus; topical. |
|
| Reprints not available from the authors. |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 87 - N° 2
P. 407-409 - août 2022 Retour au numéro
Article précédent
- No increased incidence of Clostridium difficile infection among patients with hidradenitis suppurativa treated with systemic clindamycin
- Ruby Kwak, Christina G. Lopez, Megan H. Noe, Vinod E. Nambudiri, Alexandra P. Charrow
- Association between topical corticosteroid use and fracture risk among pediatric patients with atopic dermatitis
- Reese L. Imhof, Amy L. Weaver, Jennifer St. Sauver, Jennifer Hand, Dawn Marie R. Davis, Megha M. Tollefson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?